Stefania Marcenaro

Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

Cristina Bottino, Roberta Castriconi, Daniela Pende et al. · The Journal of Experimental Medicine · 2003 · 837 citations · Full text

Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.

Daniela Pende, Paola Rivera, Stefania Marcenaro et al. · PubMed · 2002 · 504 citations

Immunology, Pathology, Immunologic Mechanism +17

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

Daniela Pende, Stefania Marcenaro, Michela Falco et al. · Blood · 2008 · 369 citations · Full text

Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)

Daniela Pende, Grazia Maria Spaggiari, Stefania Marcenaro et al. · Blood · 2004 · 360 citations

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin

Daniela Pende, Claudia Cantoni, Paola Rivera et al. · European Journal of Immunology · 2001 · 322 citations · Full text

Nonepithelial Origin, Cancer Research, Lymphoid Neoplasia +15